The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients

Jemal, 2014, Cancer statistics 2014, CA Cancer J Clin, 64, 9, 10.3322/caac.21208

Weinberg, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9

Weinberg, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013

Ladomery, 2013, Aberrant Alternative Splicing Is Another Hallmark of Cancer, Int J Cell Biol, 2013, 463786, 10.1155/2013/463786

Futreal, 2009, The cancer genome, Nature, 458, 719, 10.1038/nature07943

Castano, 2009, Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors, J Clin Endocrinol Metab, 94, 2634, 10.1210/jc.2008-2564

Zatelli, 2015, The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells, Endocrine, 50, 442, 10.1007/s12020-015-0594-x

Gahete, 2015, Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation invasion and reduced octreotide response) to somatotropinomas, Cancer Lett, 359, 299, 10.1016/j.canlet.2015.01.037

Vidal, 2014, The Truncated Isoform of Somatostatin Receptor5 (sst5TMD4) Is Associated with Poorly Differentiated Thyroid Cancer, PLoS One, 9, e85527, 10.1371/journal.pone.0085527

Castano, 2012, The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells, Oncogene, 31, 2049, 10.1038/onc.2011.389

Castano, 2011, Truncated somatostatin receptors as new players in somatostatin-cortistatin pathophysiology, Ann N Y Acad Sci, 1220, 6, 10.1111/j.1749-6632.2011.05985.x

Castaño, 2010, A potential inhibitory role for the new truncated variant of somatostatin receptor 5 (sst5TMD4) in pituitary adenomas poorly responsive to somatostatin analogs, J Clin Endocrinol Metab, 95, 2497, 10.1210/jc.2009-2247

Rich, 2006, Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor, Cancer Res, 66, 7843, 10.1158/0008-5472.CAN-06-1010

Zakharenko, 2007, A perivascular niche for brain tumor stem cells, Cancer Cell, 11, 69, 10.1016/j.ccr.2006.11.020

Rich, 2008, Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis, J Clin Oncol, 26, 2839, 10.1200/JCO.2007.15.1829

Kalluri, 2004, Cancer without disease, Nature, 427, 787, 10.1038/427787a

Benjamin, 2003, Tumorigenesis and the angiogenic switch, Nat Rev Cancer, 3, 401, 10.1038/nrc1093

Alitalo, 2009, Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system, Nat Rev Mol Cell Biol, 10, 165, 10.1038/nrm2639

Ferrara, 1993, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo, Nature, 362, 841, 10.1038/362841a0

Benjamin, 2013, Angiopoietin-2: an attractive target for improved antiangiogenic tumor therapy, Cancer Res, 73, 1649, 10.1158/0008-5472.CAN-12-4697

Del Tacca, 1996, The effects of the somatostatin analog octreotide on angiogenesis in vitro, Metabolism, 45, 49, 10.1016/S0026-0495(96)90080-3

Bagnoli, 2011, Hypoxia effects on proangiogenic factors in human umbilical vein endothelial cells: functional role of the peptide somatostatin, Naunyn Schmiedebergs Arch Pharmacol, 383, 593, 10.1007/s00210-011-0625-y

Bagnoli, 2007, Antiangiogenic role of somatostatin receptor 2 in a model of hypoxia-induced neovascularization in the retina: results from transgenic mice, Invest Ophthalmol Vis Sci, 48, 3480, 10.1167/iovs.06-1469

Bagnoli, 2003, Somatostatin inhibits potassium-evoked glutamate release by activation of the sst(2) somatostatin receptor in the mouse retina, Naunyn Schmiedebergs Arch Pharmacol, 367, 188, 10.1007/s00210-002-0662-7

Held-Feindt, 2001, Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells, Int J Cancer, 92, 545, 10.1002/ijc.1223

Cai, 2011, A randomized trial of somatostatin to regulate the VEGFs/VEGFRs in patients with gastric cancer, Hepatogastroenterology, 58, 1425, 10.5754/hge10749

Qin, 2004, Mechanisms of inhibition of growth of human pancreatic carcinoma implanted in nude mice by somatostatin receptor subtype 2, Pancreas, 29, 141, 10.1097/00006676-200408000-00009

Qin, 2004, Anti-angiogenic effects of somatostatin receptor subtype 2 on human pancreatic cancer xenografts, Carcinogenesis, 25, 2075, 10.1093/carcin/bgh216

Qin, 2004, Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression in vitro, World J Gastroenterol, 10, 393, 10.3748/wjg.v10.i3.393

Florio, 2008, Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors, Front Biosci, 13, 822, 10.2741/2722

Lamberts, 1994, Somatostatin-receptor scintigraphy in primary breast cancer, Lancet, 343, 640, 10.1016/S0140-6736(94)92637-9

Cataliotti, 2004, Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue, Endocr Relat Cancer, 11, 323, 10.1677/erc.0.0110323

Kumar, 2008, Biology of somatostatin in breast cancer, Mol Cell Endocrinol, 286, 251, 10.1016/j.mce.2008.01.006

Martin, 2007, Mechanisms of disease: angiogenesis and the management of breast cancer, Nat Clin Pract Oncol, 4, 536, 10.1038/ncpneuro0859

Spiegelman, 2008, HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha, Nature, 451, 1008, 10.1038/nature06613

Massague, 2009, Metastasis: from dissemination to organ-specific colonization, Nat Rev Cancer, 9, 274, 10.1038/nrc2622

Groom, 1998, Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases, Am J Pathol, 153, 865, 10.1016/S0002-9440(10)65628-3

Kang, 2007, Beyond tumorigenesis: cancer stem cells in metastasis, Cell Res, 17, 3, 10.1038/sj.cr.7310118

Csiszar, 2011, Lysyl oxidase-like 2 (LOXL2) a new regulator of cell polarity required for metastatic dissemination of basal-like breast carcinomas, EMBO Mol Med, 3, 528, 10.1002/emmm.201100156

Drexler, 2005, Detection of mycoplasma contaminations, Methods Mol Biol, 290, 13

Castaño, 2011, A novel human ghrelin variant (In1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: potential pathophysiological relevance, PLoS One, 6, e23302, 10.1371/journal.pone.0023302

Malagon, 2006, Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas, J Clin Endocrinol Metab, 91, 2225, 10.1210/jc.2006-0235

Gadelha, 2009, Expression analysis of dopamine receptor subtypes in normal human pituitaries nonfunctioning pituitary adenomas and somatotropinomas and the association between dopamine and somatostatin receptors with clinical response to octreotide-LAR in acromegaly, J Clin Endocrinol Metab, 94, 1931, 10.1210/jc.2008-1826

Gadelha, 2007, Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas, Eur J Endocrinol, 156, 65, 10.1530/eje.1.02313

Lopez-Miranda, 2014, Dietary fat alters the expression of cortistatin and ghrelin systems in the PBMCs of elderly subjects: putative implications in the postprandial inflammatory response, Mol Nutr Food Res, 58, 1897, 10.1002/mnfr.201400059

Clarke, 2012, A detailed mammosphere assay protocol for the quantification of breast stem cell activity, J Mammary Gland Biol Neoplasia, 17, 111, 10.1007/s10911-012-9255-3

Eliceiri, 2012, NIH Image to ImageJ: 25 years of image analysis, Nat Methods, 9, 671, 10.1038/nmeth.2089

de Medina, 2010, Reversible Ponceau staining as a loading control alternative to actin in Western blots, Anal Biochem, 401, 318, 10.1016/j.ab.2010.02.036

Hanahan, 2005, Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors, Cancer Cell, 8, 299, 10.1016/j.ccr.2005.09.005